HSBC Holdings
PHIO icon

HSBC Holdings’s Phio Pharmaceuticals PHIO Stock Holding History

HSBC Holdings’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-105
Closed -$24K – 3115
2020
Q3 		$24K Sell
105
-2
-2% -$509 ﹤0.01% 2693
2020
Q2 		$25K Sell
107
-8
-7% -$1.92K ﹤0.01% 2609
2020
Q1 		$22K Buy
115
+110
+2,200% +$67.8K ﹤0.01% 2619
2019
Q4 		$5K Buy
+5
New +$5.74K ﹤0.01% 3012

Other funds holding PHIO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HSBC Holdings's PHIO Position: Q4 2020 in Review

HSBC Holdings sold out of Phio Pharmaceuticals (PHIO) in Q4 2020, closing a stake of 105 shares — an estimated $24K sold.

HSBC Holdings first reported a position in PHIO in Q4 2019 and held it in 4 quarters. The position peaked at $25K in Q2 2020. 9 funds tracked by Wall St. Rank hold PHIO as of Q4 2020.

  • HSBC Holdings reported no remaining Phio Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • HSBC Holdings sold 105 Phio Pharmaceuticals shares in Q4 2020, an estimated $24K.
  • HSBC Holdings first reported a position in Phio Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • HSBC Holdings's Phio Pharmaceuticals position peaked at $25K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q4 2020.

Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.